HLB Life Science ranked among the top searched stocks on 9 days in the past month.


As of 1:30 PM on the 24th, HLB Life Science is trading at 28,250 KRW, down 4.24% from the previous day. This represents a 61.89% increase compared to August 27. HLB Life Science is known as an engineering service company related to energy saving.

Today, foreigners are tentatively recorded as net buyers of 144,641 shares. Over the past 5 days, individual investors have net sold 74,512 shares, while foreigners and institutions have net bought 104,749 shares and net sold 22,191 shares, respectively.


On September 21, HLB Life Science became a market issue with a 21% increase following the Phase 3 clinical trial results of ‘Rivoceranib’.





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing